Chi Chiu Mok

Summary

Affiliation: The Chinese University of Hong Kong

Publications

  1. ncbi request reprint Mucormycosis in systemic lupus erythematosus
    Chi Chiu Mok
    Departments of Medicine, Microbiology, Radiology, and Pathology, Tuen Mun Hospital, Hong Kong, China
    Semin Arthritis Rheum 33:115-24. 2003
  2. ncbi request reprint Phaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock
    C C Mok
    University Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong
    Med J Aust 166:634-5. 1997
  3. pmc Pathogenesis of systemic lupus erythematosus
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong
    J Clin Pathol 56:481-90. 2003
  4. ncbi request reprint Damage accrual in southern Chinese patients with systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong
    J Rheumatol 30:1513-9. 2003
  5. ncbi request reprint Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China
    Am J Med 115:59-62. 2003
  6. ncbi request reprint Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine
    C C Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, New Territories, SAR China
    Scand J Rheumatol 32:181-3. 2003
  7. pmc Treatment of severe proliferative lupus nephritis: the current state
    C C Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR, China
    Ann Rheum Dis 62:799-804. 2003
  8. ncbi request reprint Lupus in Hong Kong Chinese
    C C Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong Special Administrative Region, China
    Lupus 12:717-22. 2003
  9. ncbi request reprint Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR, People, s Republic of China
    Am J Kidney Dis 43:269-76. 2004
  10. ncbi request reprint Scleroderma renal crisis sine scleroderma during pregnancy
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong, SAR China
    Scand J Rheumatol 32:55-7. 2003

Collaborators

Detail Information

Publications62

  1. ncbi request reprint Mucormycosis in systemic lupus erythematosus
    Chi Chiu Mok
    Departments of Medicine, Microbiology, Radiology, and Pathology, Tuen Mun Hospital, Hong Kong, China
    Semin Arthritis Rheum 33:115-24. 2003
    ..To describe a case of mucormycosis in systemic lupus erythematosus (SLE) and to review other patients reported in the English literature...
  2. ncbi request reprint Phaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock
    C C Mok
    University Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong
    Med J Aust 166:634-5. 1997
    ..This case illustrates the diversity of presentations of phaeochromocytoma, depending on the type and amount of catecholamines secreted...
  3. pmc Pathogenesis of systemic lupus erythematosus
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong
    J Clin Pathol 56:481-90. 2003
    ..Finally, certain environmental factors are probably required to trigger the disease...
  4. ncbi request reprint Damage accrual in southern Chinese patients with systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong
    J Rheumatol 30:1513-9. 2003
    ..To study the predictive factors of damage accrual in a large cohort of southern Chinese patients with systemic lupus erythematosus (SLE)...
  5. ncbi request reprint Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China
    Am J Med 115:59-62. 2003
  6. ncbi request reprint Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine
    C C Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, New Territories, SAR China
    Scand J Rheumatol 32:181-3. 2003
    ..Prompt recognition and early aggressive immunosuppressive therapy may improve the outlook of this condition...
  7. pmc Treatment of severe proliferative lupus nephritis: the current state
    C C Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR, China
    Ann Rheum Dis 62:799-804. 2003
  8. ncbi request reprint Lupus in Hong Kong Chinese
    C C Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong Special Administrative Region, China
    Lupus 12:717-22. 2003
    ..More grants and funding are being sought for basic and clinical researches in SLE and subsidising patients to receive newer and less toxic treatment options...
  9. ncbi request reprint Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR, People, s Republic of China
    Am J Kidney Dis 43:269-76. 2004
    ..The aim of this study was to report the outcome of pure membranous lupus nephropathy treated with prednisone and azathioprine (AZA)...
  10. ncbi request reprint Scleroderma renal crisis sine scleroderma during pregnancy
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong, SAR China
    Scand J Rheumatol 32:55-7. 2003
    ..The relationship between pregnancy, scleroderma activity and renal crisis is discussed...
  11. ncbi request reprint Profile of sex hormones in male patients with systemic lupus erythematosus
    C C Mok
    Department of Medicine, Queen Mary Hospital, Hong Kong
    Lupus 9:252-7. 2000
    ..To study the profile of sex hormones in male patients with systemic lupus erythematosus (SLE)...
  12. ncbi request reprint Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome
    C C Mok
    Division of Rheumatology, Queen Mary Hospital, Pokfulam, Hong Kong
    Am J Kidney Dis 34:315-23. 1999
    ..Prospective randomized studies with well-defined treatment protocols are needed to delineate the optimal treatment strategy for LN...
  13. pmc Pregnancy in systemic lupus erythematosus
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong
    Postgrad Med J 77:157-65. 2001
    ....
  14. ncbi request reprint Use of exogenous estrogens in systemic lupus erythematosus
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital and the Department of Medicine, Queen Mary Hospital, Hong Kong
    Semin Arthritis Rheum 30:426-35. 2001
    ..To review the current literature on the safety of using exogenous estrogens in patients with systemic lupus erythematosus (SLE)...
  15. ncbi request reprint Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens
    C C Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, Hong Kong, SAR, China
    Am J Kidney Dis 38:256-64. 2001
    ..Additional randomized trials involving a larger cohort of patients with a longer period of observation are necessary...
  16. ncbi request reprint Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine
    Chi Chiu Mok
    Queen Mary Hospital, Pokfulam, Hong Kong
    Arthritis Rheum 46:1003-13. 2002
    ..To study the outcome and prognostic indicators of diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE) treated with sequential oral cyclophosphamide (CYC) and azathioprine (AZA)...
  17. ncbi request reprint Behçet's disease in southern Chinese patients
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong, SAR, China
    J Rheumatol 29:1689-93. 2002
    ..To describe the clinical characteristics of Behçet's disease (BD) in a southern Chinese population and compare them with those reported in other ethnic groups...
  18. ncbi request reprint Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese
    C C Mok
    Department of Medicine, Queen Mary Hospital, Pokfulam, Hong Kong
    J Rheumatol 25:2345-51. 1998
    ..To study the clinical characteristics, treatment outcome, and complications of patients with adult onset Still's disease (AOSD) in our local Chinese population...
  19. ncbi request reprint Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China
    Am J Med 119:355.e25-33. 2006
    ..To report the long-term outcome of diffuse proliferative lupus nephritis (DPLN) treated with cyclophosphamide (CYC) in Chinese patients...
  20. ncbi request reprint Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong, China
    Arthritis Rheum 50:2559-68. 2004
    ..To study the incidence, predictors, and outcome of renal flares after successful cyclophosphamide (CYC) treatment for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE)...
  21. doi request reprint Prevalence and risk factors of low bone mineral density in Chinese patients with systemic sclerosis: a case-control study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR China
    Rheumatology (Oxford) 52:296-303. 2013
    ..To study the prevalence and risk factors of low BMD in patients with SSc...
  22. doi request reprint Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR China
    Ann Rheum Dis 70:778-84. 2011
    ..To study the efficacy of raloxifene in preventing bone mineral density (BMD) loss in women receiving long-term glucocorticoids (GC). The study took the form of a parallel-group randomised double-blinded placebo-controlled trial...
  23. doi request reprint ELF1 is associated with systemic lupus erythematosus in Asian populations
    Jing Yang
    Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, LKS Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong, China
    Hum Mol Genet 20:601-7. 2011
    ....
  24. pmc ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai
    Wanling Yang
    Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, LKS Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong
    Hum Mol Genet 18:2063-70. 2009
    ..Therefore, despite the low-allele frequencies of the risk alleles of the gene in our two Asian populations, ITGAM was confirmed to be a risk factor related to disease susceptibility and probably severe manifestations of SLE...
  25. ncbi request reprint Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study
    Chi Chiu Mok
    Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR, China
    Medicine (Baltimore) 86:203-9. 2007
    ..67; p = 0.04). We concluded that in immune-mediated glomerulonephritis, having systemic lupus increased the risk of arterial thromboembolism after adjustment for age, renal insufficiency, and other traditional risk factors...
  26. doi request reprint Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR, China
    Rheumatology (Oxford) 51:468-75. 2012
    ..To study the BMD of patients with SLE according to the age of disease onset...
  27. pmc High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China
    Arthritis Care Res (Hoboken) 65:441-7. 2013
    ..To study the level of high-sensitivity C-reactive protein (hsCRP) and its relationship with disease activity, damage, and cardiovascular risk factors in patients with systemic lupus erythematosus (SLE)...
  28. ncbi request reprint Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong
    Medicine (Baltimore) 84:218-24. 2005
    ..Long-term survival of Chinese SLE patients is comparable to that reported for white patients in the 1990s. Late-onset SLE patients have the worst prognosis. Early damage predicts mortality...
  29. ncbi request reprint Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, China
    Arthritis Rheum 52:2774-82. 2005
    ..To compare the incidence and risk factors for thromboembolic events in systemic lupus erythematosus (SLE) patients of different ethnic backgrounds...
  30. doi request reprint Update on emerging drug therapies for systemic lupus erythematosus
    Chi Chiu Mok
    Tuen Mun Hospital, Department of Medicine and Geriatrics, New Territories, Hong Kong, Japan
    Expert Opin Emerg Drugs 15:53-70. 2010
    ..More effective but less toxic therapies through modification of existing regimens, combination strategies or more specific targeting at the immunopathogenetic pathways are necessary...
  31. pmc Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus
    Wanling Yang
    Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong
    PLoS Genet 6:e1000841. 2010
    ..These new genetic findings may help us to gain a better understanding of the disease and the functions of the genes involved...
  32. doi request reprint Venous thromboembolism in southern Chinese patients with systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, Special Administrative Region, China
    Clin Rheumatol 29:599-604. 2010
    ..36 [1.67-11.4]; p = 0.003). Although venous thrombosis is uncommon in Chinese, Chinese patients with SLE are 12 times more prone to VTE than the general population...
  33. doi request reprint Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study
    Chi Chiu Mok
    Department of Medicine and Nuclear Medicine, Tuen Mun Hospital, Hong Kong, China
    Bone 43:327-31. 2008
    ..To study the bone mineral density (BMD) and body composition in men with systemic lupus erythematosus (SLE)...
  34. ncbi request reprint Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong SAR, China
    Medicine (Baltimore) 85:221-8. 2006
    ..Primary prevention for cerebrovascular disease in high-risk patients may reduce NP damage...
  35. doi request reprint Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese
    Philip Hei Li
    Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong
    Rheumatology (Oxford) 52:337-45. 2013
    ..This study aims to identify the existence of, and relationship between autoantibody clusters and clinical subsets in Chinese SLE patients...
  36. pmc Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians
    Wanling Yang
    Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Hong Kong
    Am J Hum Genet 92:41-51. 2013
    ..For the region involving TET3 and that involving CDKN1B, multiple independent SNPs were identified, highlighting a phenomenon that might partially explain the missing heritability of complex diseases...
  37. ncbi request reprint Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong SAR, China
    Kidney Int 68:813-7. 2005
    ..The objective of the current work is to report our preliminary experience with tacrolimus in the treatment of diffuse proliferative glomerulonephritis in systemic lupus erythematosus (SLE)...
  38. ncbi request reprint Incidence and mortality of systemic lupus erythematosus in a southern Chinese population, 2000-2006
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR China
    J Rheumatol 35:1978-82. 2008
    ..To study the annual incidence and standardized mortality ratio (SMR) of a longitudinal cohort of Chinese patients with systemic lupus erythematosus (SLE)...
  39. ncbi request reprint Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus
    Shuk Yi Chau
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong SAR, China
    Neurology 61:104-7. 2003
    ..After multivariate adjustment, only hypoalbuminemia remained significant...
  40. doi request reprint Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR China
    Transl Res 156:320-5. 2010
    ..The anti-C1q antibody, however, is more specific than anti-dsDNA for both active renal and extrarenal lupus. The absence of both anti-dsDNA and anti-C1q has a high NPV for renal activity...
  41. ncbi request reprint Rituximab for refractory polymyositis: an open-label prospective study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, China
    J Rheumatol 34:1864-8. 2007
    ..To report the efficacy and toxicity of rituximab in the treatment of refractory polymyositis...
  42. ncbi request reprint Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, Special Administrative Region, China
    Am J Med 117:791-5. 2004
  43. doi request reprint Prevalence of the antiphospholipid syndrome and its effect on survival in 679 chinese patients with systemic lupus erythematosus: a cohort study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, China
    Medicine (Baltimore) 92:217-22. 2013
    ..2) Arterial thrombosis is a more common manifestation of APS than venous thrombosis in Chinese SLE patients. 3) APS related to arterial thrombosis is associated with increased mortality in Chinese patients with SLE. ..
  44. doi request reprint Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis
    Chi Chiu Mok
    Tuen Mun Hospital, Chinese University of Hong Kong, Hong Kong, China
    Arthritis Care Res (Hoboken) 63:195-202. 2011
    ..To evaluate the prevalence of the metabolic syndrome in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA)...
  45. ncbi request reprint Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis
    Yui Pong Siu
    Department of Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong, China
    Nephrol Dial Transplant 20:2797-802. 2005
    ..The purpose of this study was to evaluate the outcome of systemic lupus erythematosus (SLE) patients on continuous ambulatory peritoneal dialysis (CAPD)...
  46. ncbi request reprint Raloxifene for postmenopausal women with systemic lupus erythematosus: a pilot randomized controlled study
    Chi Chiu Mok
    Tuen Mun Hospital, Hong Kong, China
    Arthritis Rheum 52:3997-4002. 2005
    ..To study the effects of raloxifene on disease activity and bone mineral density (BMD) in postmenopausal women with systemic lupus erythematosus (SLE)...
  47. doi request reprint Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study
    Chi Chiu Mok
    Department of Medicine, Tuen Mun and Pok Oi Hospital, New Territories, Hong Kong, SAR China
    Ann Rheum Dis 72:659-64. 2013
    ..To evaluate the immunogenicity and safety of GARDASIL, a quadrivalent human papillomavirus (HPV) vaccine, in patients with systemic lupus erythematosus (SLE)...
  48. doi request reprint Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong, SAR, China
    Rheumatology (Oxford) 51:644-52. 2012
    ..To study the relationship of 25(OH)D(3) level with disease activity, vascular risk factors and atherosclerosis in SLE...
  49. doi request reprint Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis
    Eugenia Yung Ching Lok
    correspondence and M D, FRCP, Chief of Rheumatology, Dept of Medicine, Tuen Mun Hospital, New Territories, Hong Kong, SAR, China
    Psychosomatics 51:338-338.e8. 2010
    ..33%-0.35%. The resulting chronic pain, disability, social stress, and isolation contribute to the development of psychiatric symptoms...
  50. doi request reprint Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma
    Chi Chiu Mok
    Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Center for Assessment and Treatment of Rheumatic Diseases, Pok Oi Hospital, Hong Kong
    Nat Rev Nephrol 5:212-20. 2009
    ..Controlled trials to compare existing immunosuppressive agents and experimental modalities such as sirolimus, rituximab and infliximab should be undertaken in the future...
  51. ncbi request reprint Treatment for lupus nephritis: a revisit
    Kar Neng Lai
    Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
    Nephrology (Carlton) 10:180-8. 2005
    ..The potential of other new therapeutic agents is discussed together with the need for patient recruitment in future trials of lupus nephritis to address the importance of ethnicity as well as histological grading...
  52. pmc Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong
    Clin Rheumatol 30:303-12. 2011
    ....
  53. ncbi request reprint Who should treat lupus nephritis: rheumatologists or nephrologists?
    Chi Chiu Mok
    Division of Rheumatology, Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, Hong Kong, China
    Nat Clin Pract Nephrol 4:E1. 2008
  54. doi request reprint Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial
    Chi Chiu Mok
    Tuen Mun Hospital, Hong Kong, China
    Arthritis Care Res (Hoboken) 63:875-83. 2011
    ..To study the effect of rosuvastatin on vascular biomarkers and carotid intima-media thickness (IMT) in systemic lupus erythematosus (SLE)...
  55. doi request reprint Erythema elevatum diutinum in systemic lupus erythematosus
    Yung Chan
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong
    Rheumatol Int 31:259-62. 2011
    ..Skin biopsy confirmed the diagnosis of EED. Treatment with dapsone resulted in complete resolution of the skin lesions. EED is rarely reported in SLE, and its presentation and treatment is reviewed...
  56. pmc Biomarkers for lupus nephritis: a critical appraisal
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases, Pok Oi Hospital, Hong Kong
    J Biomed Biotechnol 2010:638413. 2010
    ..This paper reviews promising biomarkers that have recently been evaluated in longitudinal studies of lupus nephritis...
  57. ncbi request reprint Therapeutic options for resistant lupus nephritis
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, Hong Kong, SAR China
    Semin Arthritis Rheum 36:71-81. 2006
    ..To summarize the therapeutic options for proliferative and membranous lupus nephritis that is resistant to conventional treatment...
  58. doi request reprint Hormone replacement therapy in systemic lupus erythematosus
    Chi Chiu Mok
    Center for Assessment and Treatment of Rheumatic Diseases, Tuen Mun and Pok Oi Hospital, Hong Kong, China
    Nat Clin Pract Rheumatol 4:60-1. 2008
  59. ncbi request reprint Mycophenolate mofetil in lupus glomerulonephritis
    Chi Chiu Mok
    Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong
    Am J Kidney Dis 40:447-57. 2002
    ..However, the lack of long-term efficacy data and comparative studies with standard CYC regimens is the major deterrent for the first-line use of MMF in high-risk patients at this juncture...
  60. ncbi request reprint Emerging drug therapies for systemic lupus erythematosus
    Chi Chiu Mok
    Department of Medicine and Geriatrics, Tuen Mun Hospital, New Territories, Hong Kong, China
    Expert Opin Emerg Drugs 11:597-608. 2006
    ..This article reviews the emerging therapeutic modalities that have been used or are being tried in patients with SLE...
  61. ncbi request reprint Cyclophosphamide for severe lupus nephritis: where are we now?
    Chi Chiu Mok
    Arthritis Rheum 50:3748-50. 2004
  62. ncbi request reprint Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica
    Chi Chiu Mok
    Department of Medicine and Radiology, Tuen Mun Hospital, Hong Kong SAR
    J Rheumatol 35:172-4. 2008
    ....